Results for “ ”

Entry Author Date Location
Bio Roundup: Biogen’s Reversal, FDA Moves Fast, a CF Cocktail & More 10/25/19 National
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More 10/18/19 National
Bio Roundup: Nobel Prizes, Placebo Effect Rises, ICER’s Fire & More 10/11/19 National
The Placebo Effect Is Hobbling New Psychiatric Drugs. What Can Stop It? 10/10/19 National
Five Years After Y Combinator First Admits Biotechs, They’re Dug In 10/09/19 San Francisco
Bio Roundup: PARP Progress, A New Commish, IPO-Palooza & More 10/04/19 National
Nuance Spinout Cerence Vies With Tech Giants in Voice-AI for Auto 10/02/19 San Francisco
Can Ford’s Self-Driving Car Business Improve Austin’s Traffic Woes? 10/01/19 Texas
ESMO 2019: PARP and Prostate, SeaGen’s Win, KRAS Update & More 10/01/19 National
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More 09/27/19 National
Report: IPO Activity Picking Back Up Following Quiet, Volatile Q3 09/25/19 San Diego
CyberFortress Adds $3M Seed Round for Cybersecurity Insurance Tech 09/25/19 Texas
Bio Roundup: Pelosi’s Reveal, Alder’s Deal, Biogen’s Fails & More 09/20/19 National
Pelosi, Dems Unveil Price Plan: Are 25 Drugs Enough for Negotiation? 09/19/19 National
HMS’s $36M Deal to Buy VitreosHealth Combines Complementary Firms 09/17/19 Texas
Why Menlo Ventures Backed Construction Tech Firm Fieldwire 09/16/19 San Francisco
Bio Roundup: Award Winners, Lung Data, Dems on Drug Pricing & More 09/13/19 National
After First Look at House Drug Plan, Stocks Rise Slightly 09/10/19 National
Herceptin Inventors, Immunology Pioneers Take Home 2019 Lasker Awards 09/10/19 National
Amazon, With More WA Workers than Microsoft, Eyes Adding 10K More 09/09/19 Seattle
At Big Lung Cancer Meeting, Lights Shine on KRAS, Drug Combos & More 09/09/19 National
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone 09/06/19 National
Robocalls Crowd Out Real Business Calls. This Startup Has an Answer. 08/30/19 Seattle
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More 08/30/19 National
Celgene Adds Cell Therapies From Immatics With Bristol Sale in Sight 08/28/19 New York
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.) 08/26/19 National
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More 08/23/19 National
VMware Dropping $4.8B to Buy Carbon Black, Pivotal Software 08/22/19 Boston
Ford’s Autonomic Connects EV Maker Ayro to Its Mobility Cloud 08/21/19 San Francisco
Bio Roundup: Zolgensma Fallout, Duchenne Redux, Ebola Boost & More 08/16/19 National
Page 3 of 97 « previous page · next page »